株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アジア太平洋地域における感染症POCT (臨床現場即時検査) 市場の予測:~2023年

Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023

発行 Frost & Sullivan 商品コード 866656
出版日 ページ情報 英文 74 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.24円で換算しております。
Back to Top
アジア太平洋地域における感染症POCT (臨床現場即時検査) 市場の予測:~2023年 Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023
出版日: 2019年06月07日 ページ情報: 英文 74 Pages
概要

アジア太平洋地域における感染症POCT (臨床現場即時検査) の市場は結核、HIV、肝炎の罹患率の上昇、携帯型POCT機器の開発などの要因によって推進される見通しです。

当レポートでは、アジア太平洋地域における感染症POCT (臨床現場即時検査) の市場を調査し、市場の背景・概要、バリューチェーン、市場成長への各種影響因子の分析、主な市場動向・技術動向、主要5カ国の展望、疾患領域別の収益規模の推移と予測、競合環境と市場シェア、成長機会・成功因子の分析などをまとめています。

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の背景・概要
  • バリューチェーン分析

第3章 推進因子と障壁

第4章 市場動向

  • 技術動向
  • 主要動向・事業への影響
  • 感染症診断の技術イニチアチブ

第5章 市場力学

  • 市場の方向性
  • 市場分析
  • 感染症サーベイランス
  • 主要5カ国の展望
  • 中国の主な医療改革:タイムライン
  • 中国におけるPOCT:市場力学
  • 日本におけるPOCT:市場力学
  • 東南アジアの結核プログラム

第6章 市場予測・市場動向

  • マーケットエンジニアリング測定
  • 収益予測:前提因子
  • 収益予測
  • 収益予測に関するディスカッション
  • 市場機会:疾患領域別

第7章 競合分析

  • 参入事業者の概要
  • 市場シェア分析
  • 注目の企業
  • 競合環境
  • 競合因子の分析
  • 競合ベンチマーキング:POCTソリューションプロバイダー
  • 主なM&A・提携

第8章 ビジョニングシナリオ

第9章 成長機会

  • エコシステムのトランスフォーメーション
  • 主な成長機会
  • 成長機会:許容価格のPOC結核診断キット
  • 成長機会:薬剤耐性菌 (AMR) 感染の有病率の増加
  • 成長機会:ポータブルリアルタイム診断マシン
  • 成長機会:普及不足のインドネシア市場
  • 成功・成長のための戦略的必須要件

第10章 総論

  • 総論:三大予測
  • 免責事項

第11章 付録

第12章 FROST & SULLIVANについて

目次
Product Code: PA00-55

The Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices will Propel the APAC Infectious Diseases POCT Market

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests.

The Asia-Pacific shows the highest prevalence of infectious diseases, such as tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs). Countries such as India, China, and Indonesia are some of the leading contributors to these life-threatening infections. Hence, the Asia-Pacific stands out as a key contributor to the global infectious diseases diagnostics market.

With the rising disease prevalence, companies are shifting their business models to a more consumer-oriented approach. Steps are being taken to ensure a direct contact with the consumer/end user by means of direct-to-consumer selling using ecommerce portals such as Amazon. Alongside retail selling, vendors such as Alibaba ensure a bulk dispatch of diagnostic devices to hospitals and clinics, thereby playing a crucial role in the diagnostic value chain. The study also highlights some of the innovative payment models which result in improved patient access to these high value therapies. Information on some of the emerging business models across the cell therapy market, such as risk sharing, fast to market business models, etc., has also been provided.

Key Features:

The study aims to identify some of the key growth opportunities which are set to drive the market in the next few years. It provides a revenue analysis of the total Asia-Pacific infectious diseases POCT market with an analysis of the specific regional players as well as the most common infectious disease diagnostics. The study also highlights some of the key market drivers and restraints which affect the growth. Additionally, it gives an insight on the leading market trends shaping the industry and their long-term implications on market growth. It also focuses on some of the country-specific regulatory policies and their impact on the adoption of innovative diagnostics solutions.

Key Issues Addressed:

  • What are the biggest opportunities for companies in the infectious disease point-of-care testing space?
  • How are the various countries within the Asia-Pacific positioned to monetize the market opportunities?
  • What is the total market size and projected growth of POCT solutions for infectious diseases?
  • What are the key success factors for companies to remain relevant and competitive in this market?
  • How are product offerings in this market likely to emerge? How are transitions taking place across the value chain to solve the unmet needs from customers?

Table of Contents

1. EXECUTIVE SUMMARY-MARKET SNAPSHOT

  • Key Findings
  • Key Findings (continued)
  • Executive Summary-Market Engineering Measurements
  • Scope and Segmentation
  • Key Questions Addressed in this Study
  • 6 Big Themes for the Infectious Disease POCT Market of the Future

2. MARKET OVERVIEW

  • Market Background and Overview
  • Value Chain Analysis
  • Value Chain Analysis (continued)

3. DRIVERS AND RESTRAINTS-INFECTIOUS DISEASES POCT MARKET

  • Drivers and Restraints

4. TRENDS IN INFECTIOUS DISEASE POCT

  • Technology Trends in the APAC Infectious Diseases POCT Market
  • Key Trends and Impact on Business
  • Technology Initiatives for Infectious Disease Diagnosis in APAC

5. MARKET DYNAMICS-APAC

  • Where is the Market Heading?
  • Market Analysis
  • Infectious Diseases Surveillance in APAC
  • Regional Perspectives for Infectious POCT Market in APAC-Top 5 Countries
  • Key Healthcare Reforms in China-Timeline
  • POCT in China-Market Dynamics
  • POCT in Japan-Market Dynamics
  • Tuberculosis Programmes in Southeast Asia

6. FORECASTS AND TRENDS-INFECTIOUS DISEASES POCT MARKET

  • Market Engineering Measurements
  • Revenue Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Market Opportunity by Disease Area

7. COMPETITIVE PLAYBOOK

  • Snapshot of Market Participants
  • Snapshot of Market Participants (continued)
  • Market Share Analysis
  • Key Companies to Watch
  • Key Companies to Watch (continued)
  • Competitive Environment
  • Competitive Factors Assessment
  • Competitive Benchmarking-POCT Solution Providers
  • Competitive Benchmarking-POCT Solution Providers (continued)
  • Key Mergers, Acquisitions, and Partnership Assessment

8. VISIONING SCENARIOS

  • Visioning Scenarios for the Infectious Disease POCT Market
  • Business Models-Business to business to consumer (B2B2C) Models
  • Emerging Business Models-D2B2C* Models

9. GROWTH OPPORTUNITIES

  • Transformation in Industry Ecosystem
  • 4 Major Growth Opportunities
  • Growth Opportunity 1-Affordable POC Tuberculosis Diagnostic Kit
  • Growth Opportunity 2-Growing Prevalence of Anti-microbial Resistance (AMR) Infections
  • Growth Opportunity 3-Portable Real-time Diagnostic Machines
  • Growth Opportunity 4-Under-penetrated Indonesian Market
  • Strategic Imperatives for Success and Growth

10. THE LAST WORD

  • The Last Word-Three Big Predictions
  • Legal Disclaimer

11. APPENDIX

  • Abbreviations
  • List of Exhibits

12. THE FROST & SULLIVAN STORYTHE JOURNEY TO VISIONARY INNOVATION

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top